Developing 212Pb Based RICs as Powerful Targeted Therapies (en anglais)

31 janvier 2013

Developing 212Pb Based RICs as Powerful Targeted Therapies

EMIT Targeted Radiotherapy Conference

January 2013

Julien Torgue, Scientific Director, AREVA Med

Ruby Meredith, Professor, University of Alabama

Abstract

  • Developing an integrated model for RIT
  • Phase I clinical trial design overview and initial results

http://targeted-radiotherapy.com/agenda/day-one

Vidéo AREVA Med

Cliquez ici pour voir la vidéo

Contact

Pour plus d'informations à propos d'AREVA Med, veuillez contacter :
Alison Tise
Tel.: + 1 (301) 841-1673